Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

LDN-212320

🥰Excellent
Catalog No. T15728Cas No. 894002-50-7
Alias OSU-0212320, LDN-0212320, LDN/OSU-0212320

LDN-212320 (OSU-0212320) is a glutamate transporter EAAT2 activator. It also enhances EAAT2 levels by > 6 fold at concentrations < 5 μM after 24 h.

LDN-212320

LDN-212320

🥰Excellent
Purity: 98.13%
Catalog No. T15728Alias OSU-0212320, LDN-0212320, LDN/OSU-0212320Cas No. 894002-50-7
LDN-212320 (OSU-0212320) is a glutamate transporter EAAT2 activator. It also enhances EAAT2 levels by > 6 fold at concentrations < 5 μM after 24 h.
Pack SizePriceAvailabilityQuantity
2 mg$39In Stock
5 mg$64In Stock
10 mg$98In Stock
25 mg$198In Stock
50 mg$373In Stock
100 mg$560In Stock
500 mg$1,190In Stock
1 mL x 10 mM (in DMSO)$70In Stock
Bulk & Custom
Add to Cart
Questions
View More

Related Compound Libraries of "LDN-212320"

Select Batch
Purity:98.13%
Contact us for more batch information
Resource Download
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.

Product Introduction

Bioactivity
Description
LDN-212320 (OSU-0212320) is a glutamate transporter EAAT2 activator. It also enhances EAAT2 levels by > 6 fold at concentrations < 5 μM after 24 h.
In vitro
LDN/OSU-0212320 enhanced EAAT2 protein levels and glutamate uptake function but did not affect EAAT1 or EAAT3 protein levels and it also increased EAAT2 protein levels in a dose-dependent (EC50: 1.83 ± 0.27 μM) and time-dependent manner. LDN/OSU-0212320 treatment markedly prevented neuronal loss and degeneration, as assessed by MAP2 immunostaining [2].
In vivo
After LDN/OSU-0212320(a single i.p.; 40-mg/kg) treatment, EAAT2 protein levels and associated glutamate uptake increased by approximately 1.5- to 2-fold at 2 hours and by approximately 2- to 3-fold between 8 and 24 hours after injection. Even 72 hours after injection, an approximately 1.5-fold increase in EAAT2 protein levels could still be detected (data not shown). LDN/OSU-0212320–induced EAAT2 protein levels and glutamate uptake was dose-dependent [2].
AliasOSU-0212320, LDN-0212320, LDN/OSU-0212320
Chemical Properties
Molecular Weight293.39
FormulaC17H15N3S
Cas No.894002-50-7
SmilesCc1ccccc1CSc1ccc(nn1)-c1ccccn1
Relative Density.no data available
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.
Solubility Information
DMSO: 16.67 mg/mL (56.81 mM), Sonication is recommended.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM3.4084 mL17.0422 mL34.0843 mL170.4216 mL
5 mM0.6817 mL3.4084 mL6.8169 mL34.0843 mL
10 mM0.3408 mL1.7042 mL3.4084 mL17.0422 mL
20 mM0.1704 mL0.8521 mL1.7042 mL8.5211 mL
50 mM0.0682 mL0.3408 mL0.6817 mL3.4084 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
TargetMol | Animal experimentsFor example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . TargetMol | Animal experiments A total of 10 animals were administered, and the formula you used is 5% TargetMol | reagent DMSO+30% PEG300+5% Tween 80+60% ddH2O. So your working solution concentration is 2 mg/mL。
Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSOTargetMol | reagent (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
Preparation method for in vivo formula: Take 50 μL DMSOTargetMol | reagent main solution, add 300 μLPEG300TargetMol | reagent mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2OTargetMol | reagent mix well and clarify
For Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
%Tween 80
%ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy LDN-212320 | purchase LDN-212320 | LDN-212320 cost | order LDN-212320 | LDN-212320 chemical structure | LDN-212320 in vivo | LDN-212320 in vitro | LDN-212320 formula | LDN-212320 molecular weight